These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 19074895

  • 1. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
    Sakai Y, Honda M, Fujinaga H, Tatsumi I, Mizukoshi E, Nakamoto Y, Kaneko S.
    Cancer Res; 2008 Dec 15; 68(24):10267-79. PubMed ID: 19074895
    [Abstract] [Full Text] [Related]

  • 2. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.
    Ann Surg Oncol; 2006 Jul 15; 13(7):947-54. PubMed ID: 16788756
    [Abstract] [Full Text] [Related]

  • 3. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S, Iwashita Y, Sasaki A, Kai S, Ohta M, Kitano S.
    J Gastroenterol Hepatol; 2007 May 15; 22(5):690-6. PubMed ID: 17444857
    [Abstract] [Full Text] [Related]

  • 4. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.
    Int J Oncol; 2006 Aug 15; 29(2):315-27. PubMed ID: 16820872
    [Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR, Maluf DG, Stravitz R, Dumur CI, Clark B, Rodgers C, Ferreira-Gonzalez A, Fisher RA.
    Liver Transpl; 2004 May 15; 10(5):607-20. PubMed ID: 15108252
    [Abstract] [Full Text] [Related]

  • 6. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.
    Cancer Res; 2009 Feb 15; 69(4):1358-67. PubMed ID: 19190340
    [Abstract] [Full Text] [Related]

  • 7. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
    Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G.
    Cancer Res; 2001 Apr 01; 61(7):3176-81. PubMed ID: 11306505
    [Abstract] [Full Text] [Related]

  • 8. Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma.
    Yamashita T, Kaneko S, Hashimoto S, Sato T, Nagai S, Toyoda N, Suzuki T, Kobayashi K, Matsushima K.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):647-54. PubMed ID: 11401510
    [Abstract] [Full Text] [Related]

  • 9. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
    Wu LQ, Lu Y, Wang XF, Lv ZH, Zhang B, Yang JY.
    Life Sci; 2006 Jul 17; 79(8):744-8. PubMed ID: 16546222
    [Abstract] [Full Text] [Related]

  • 10. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma.
    Liu Y, Poon RT, Feng X, Yu WC, Luk JM, Fan ST.
    Am J Gastroenterol; 2004 Jun 17; 99(6):1111-21. PubMed ID: 15180734
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy.
    Yamauchi K, Akbar SM, Horiike N, Michitaka K, Onji M.
    Int J Mol Med; 2003 May 17; 11(5):601-5. PubMed ID: 12684696
    [Abstract] [Full Text] [Related]

  • 13. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
    Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M, Zatloukal K.
    Gastroenterology; 2007 Jan 17; 132(1):330-42. PubMed ID: 17241883
    [Abstract] [Full Text] [Related]

  • 14. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 15. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
    Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB, Schirmacher P.
    Cancer Res; 2004 Sep 01; 64(17):6058-64. PubMed ID: 15342387
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
    Burczynski ME, Twine NC, Dukart G, Marshall B, Hidalgo M, Stadler WM, Logan T, Dutcher J, Hudes G, Trepicchio WL, Strahs A, Immermann F, Slonim DK, Dorner AJ.
    Clin Cancer Res; 2005 Feb 01; 11(3):1181-9. PubMed ID: 15709187
    [Abstract] [Full Text] [Related]

  • 17. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.
    Int J Oncol; 2006 Feb 01; 28(2):383-91. PubMed ID: 16391793
    [Abstract] [Full Text] [Related]

  • 18. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
    Bureau C, Péron JM, Bouisson M, Danjoux M, Selves J, Bioulac-Sage P, Balabaud C, Torrisani J, Cordelier P, Buscail L, Vinel JP.
    J Gastroenterol Hepatol; 2008 Jan 01; 23(1):78-86. PubMed ID: 18171345
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW, Chen YX, Wang ZM, Zhou LD, Li XY, Li LX, Luo QZ, Tian W, Fu CY, Zhou JH.
    Hepatogastroenterology; 2008 Jan 01; 55(82-83):345-50. PubMed ID: 18613363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.